

The Biosimilars LatAm – Brazil 2022 is providing in-depth local analysis and information regarding commercialization strategies, regulation, good manufacturing and distribution practices, international market trends and more.
With a particular focus on providing insight into the clinical practice and prescription of these drugs in the country, seeking for a greater access to biological treatments for patients in Brazil.

Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
From these areas:
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Speaker Board
Program at a Glance
Latest News on Regulatory Processes
Tendering Procedures: Healthy Competition and Public Health
Biosimilars Market Innovation: from Developing a Mindset for Global Competitiveness to Business Strategies
PDP’s Success Stories
Good Distribution Practices: Stakeholders Perspective
Case Study: European Market Dynamics
Full programme in the PDF Agenda
Download Agenda

Sponsors
Photo Gallery from Previous Events
